mediated by dermal dendritic cells, thus, any drug down-regulating T cells, such as imatinib in our cases, might favour the appearance of multiple DF through an exaggerated response to an unknown pathogen. We found only one case report of MEDF in a patient with CML. That case occurred after an aplastic episode and the authors considered the MEDF secondary to immunosuppression. Our second case c...
